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Edited by Maurice MontalAbstract Lysophosphatidylcholine rapidly paralyses the neuro-
muscular junction (NMJ), similarly to snake phospholipase A2
neurotoxins, implicating a lipid hemifusion-pore transition in
neuroexocytosis. The mode and kinetics of NMJ paralysis of
diﬀerent lysophospholipids (lysoPLs) in high or low [Mg2+]
was investigated. The following order of potency was found:
lysophosphatidylcholine > lysophosphatidylethanolamine > lyso-
phosphatidic acid > lysophosphatidylserine > lysophosphatidyl-
glycerol. The latter two lysoPLs closely mimic the proﬁle of
paralysis caused by the toxins in high [Mg2+]. This paralysis is
fully reversed by albumin washing. These ﬁndings provide novel
insights on the mode of action of snake neurotoxins and qualify
lysoPLs as novel agents to study neuroexocytosis.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Many venomous snake species produce presynaptic neuro-
toxins endowed with phospholipase A2 activity (SPANs)
which play a major role in envenomation. These neurotoxins
cause a persistent blockade of neurotransmitter release from
nerve terminals [1–5].
The induction of neuromuscular transmission failure by
SPANs is traditionally measured in nerve–muscle preparations
isolated from the mouse hemidiaphragm or the chicken biven-
ter cervicis. Such measurements can be performed in buﬀers
containing either low (1 mM) or high (5–7 mM) Mg2+ concen-
trations ([Mg2+]). The former one is close to the physiological
concentration, but the latter [Mg2+] provides the advantage of
faster toxin eﬀect and higher reproducibility. Nearly all the re-
ports on the neuromuscular blockade with SPANs, present in
the literature, were conducted under the latter condition. In theAbbreviations: FA, fatty acids; OA, oleic acid; SPAN, snake phospho-
lipase A2 presynaptic neurotoxin; lysoPC, lysophosphatidylcholine;
lysoPE, lysophosphatidylethanolamine; lysoPS, lysophosphatidylser-
ine; lysoPG, lysophosphatidylglycerol; lysoPA, lysophosphatidic acid;
lysoPL, lysophospholipid; SVs, synaptic vesicles; [Mg2+], magne-
sium concentration; PLA2, phospholipase A2; neuromuscular junc-
tion, NMJ
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doi:10.1016/j.febslet.2006.10.039presence of 5–7 mM Mg2+, the curve of the paralysis induced
by SPANs is triphasic, as shown in Fig. 1A. An initial phase
of weak inhibition of acetylcholine release is followed by a sec-
ond prolonged phase of facilitated release which merges into a
third phase of progressive decline of neurotransmission [6–8].
Electron microscopy performed at the third stage shows swol-
len and enlarged axon terminals with depletion of synaptic ves-
icles (SVs) [1,9–13]. We recently showed that SPANs block the
neurotransmission by promoting fusion of SVs with the pre-
synaptic membrane and by inhibiting their retrieval, at the
same time [14,15]. Moreover, we showed that all the functional
and morphological alterations caused by SPANs can be in-
duced by incubation with their phospholipids hydrolysis prod-
ucts, i.e. lysophosphatidylcholine (lysoPC) and fatty acids
(FA) [16]. These ﬁndings were explained on the basis of the
known eﬀect of the inverted cone-shaped lysoPC and cone-
shaped FA on membrane fusion, as they promote the transi-
tion from lipid hemifusion intermediates to an open pore
[16–18].
Among lysophospholipids (lysoPLs), only lysoPC was inves-
tigated previously [16]. We have extended these studies to the
major classes of lysoPL, with diﬀerent head-groups, either
alone or mixed with fatty acid, and we present here their eﬀects
on the mode and kinetics of induction of paralysis of the
mouse hemidiaphragm neuromuscular junction. Oleic acid
(OA) was used in each case because it is a major FA of the neu-
ronal membrane and for the sake of comparison with previous
data. We also report the remarkable ﬁnding that the nerve ter-
minal inhibition induced by these lipid mixtures and by SPANs
is reversed by washings with the lipid binding protein albumin
showing that these inhibitors induce paralysis without causing
permanent damage to the tissue under our experimental condi-
tions.2. Materials and methods
2.1. Materials
Taipoxin and textilotoxin were purchased from Venom Supplies
(Tanunda, South Australia); b-BTx was from Sigma (Saint Louis,
MS, USA). Purity was checked by sodium-dodecyl-sulfate polyacryl-
amide-gel electrophoresis (SDS–PAGE) and PLA2 activity measured
with a secretory PLA2 assay kit (Cayman Chemical Company, Ann
Arbor, MI) [19]. Bovine serum albumin (BSA) was from Roche
(Indianapolis, IN, USA). Lysophosphatidylcholine (1-myristoyl-2-
hydroxy-sn-glycero-3-phosphocholine and 1-oleoyl-2-hydroxy-sn-gly-
cero-3-phosphocholine) and OA (sodium salt) were purchased from
Sigma. Lysophosphatidylethanolamine (1-myristoyl-2-hydroxy-sn-
glycero-3-phosphoethanolamine), lysophosphatidylserine (1-oleoyl-2-
hydroxy-sn-glycero-3-phosphoserine), lysophosphatidylglycerol (1-
myristoyl-2-hydroxy-sn-glycero-3-[phospho-rac-(1-glycerol)]) (sodiumblished by Elsevier B.V. All rights reserved.
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Fig. 1. Paralysis of the neuromuscular preparation in low or high
[Mg2+] buﬀers. Time courses of the inhibition of the mouse hemidia-
phragm NMJ caused by taipoxin (1 lg/ml) in high (A) and low [Mg2+]
(C) buﬀers. Closely similar traces were obtained with b-bungarotoxin
and textilotoxin (not shown). These neurotoxins induce a triphasic
proﬁle, consisting of an initial rapid depression phase (1), a facilitation
phase (2), and a ﬁnal run-down phase (3). The inhibition proﬁle
obtained in low [Mg2+] is characterized by a long lag phase before the
run-down phase. Panels B and D report the paralysis proﬁle obtained
upon addition in the bathing medium of a 1:1 mixture of myristoyl-
lysoPC and OA (ﬁnal concentration 150 lM each). Also in this case
the low [Mg2+] trace (D) shows a long lag phase. Toxins or lipids are
added at time 0. For comparison of diﬀerent experiments, the
stabilized initial twitching strength was taken as 100%; each trace is
representative of at least three experiments.
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phosphate) (sodium salt) were obtained from Avanti Polar lipids (Ala-
baster, AL, USA).2.2. Lipids preparation
Suitable aliquotes of lysoPL were dissolved in small volumes of
CHCl3:CH3OH (3:1, v/v), dried to a thin ﬁlm under a gentle nitrogen
ﬂow and vacuum pumped for at least 2 h to remove residual traces of
organic solvents. The dried lipid ﬁlm was suspended in buﬀer L
(Hepes-Na 10 mM, pH 7.4, NaCl 150 mM) at ﬁnal concentration of
2.5 mM, extensively vortexed and then ultrasonically dispersed in a
bath sonicator at 37– 40 C, until optical clarity was obtained. OA
was suspended in buﬀer L (ﬁnal concentration 10 mM), vortexed and
ultrasonically dispersed with the same procedure. When required, Ly-
soPL and OA suspensions were mixed in a 1:1 molar ratio and ultra-
sonically dispersed for additional 10 min. All suspensions were kept
at 37– 40 C until use.2.3. Mouse phrenic nerve-hemidiaphragm preparation
All experimental procedures were carried out in accordance to the
European Communities Council Directive no. 86/609/EEC. Mouse
phrenic nerve hemidiaphragms were isolated from CD-1 mice weighing
about 20–30 g as previously described [20] and mounted in 20 ml oxy-
genated (95% O2, 5% CO2) physiological buﬀer (139 mM NaCl,
12 mM NaHCO3, 4 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 1 mM
KH2PO4 and 11 mM glucose, pH 7.4). Two innervated hemidia-
phragm preparations were isolated from each animal.
The phrenic nerve was stimulated via two ring platinum electrodes
with supramaximal stimuli of 10 V amplitude and 0.1 ms pulse dura-
tion, with a frequency of 0.1 Hz (Stimulator 6002, Harvard Apparatus,
Massachusetts, USA). Muscle contraction was monitored with an iso-
metric transducer (Harvard Apparatus); data were recorded via an NI
DAQCard-6062E and analyzed by a LabView-based computer pro-gram (National Instruments, Austin, Texas, USA); the amplitude of
twitch was calculated as a diﬀerence from basal muscular tension
and the mean of peak value measured after stimulation.
Muscles were stretched to the optimal length for twitch tension and
the muscle twitch allowed to stabilize for at least 20 min at 37 C. In
control experiments the amplitude of muscle contraction under this
type of stimulation was constant for at least 8 h. In high [Mg2+] experi-
ments, aliquots of a 0.5 M solution of MgCl2 were added to the bath
to achieve a twitch reduction from 45 to 55% of initial stabilized
twitch, which correspond to a ﬁnal [Mg2+] of 5–7 mM, in diﬀerent
preparations. Muscles were equilibrated for further 15–20 min; the
mean twitch value measured during the last 5–10 min before the addi-
tion of toxin or lipids was taken as 100% in order to normalize the
experiments.
Taipoxin, textilotoxin (1 lg/ml) or b-bungarotoxin (3 lg/ml) were
added to the nerve–muscle preparations in the minimal volume of buf-
fer; lipids or lipid mixtures were added to 20 ml bath medium at the
ﬁnal concentration of 150 lM (for each lipids) and twitch failure was
monitored. In all cases, after complete paralysis of the neuromuscular
preparation, direct stimulation of the muscle was performed to exclude
any myotoxic eﬀect of the compounds tested.
2.4. Albumin washing
After muscle paralysis in high [Mg2+], nerve stimulation was sus-
pended and the medium was rapidly discarded and replaced with phys-
iological buﬀer (pre-oxygenated and pre-warmed) containing 0.2% w/v
of bovine albumin (washing buﬀer). After 5 min, the washing buﬀer
was removed, the nerve–muscle preparation extensively washed with
pre-warmed physiological buﬀer, and then nerve stimulation was re-
established.3. Results
3.1. Eﬀects of [Mg2+] on the neuromuscular junction paralysis
induced by snake neurotoxins or lysophospholipids/fatty
acid mixtures
The triphasic curve of paralysis of the neuromuscular junc-
tion (NMJ) exhibited by SPANs is observed only when the
bathing medium contains a high [Mg2+] (Fig. 1A), whilst in
physiological [Mg2+] a simple run-down type of curve is ob-
tained (Fig. 1C). Very similar paralysis curves were observed
with the three SPAN neurotoxins used here: b-bungarotoxin,
taipoxin and textilotoxin. The molecular events underlying
phases 1 and 2 (only present in high [Mg2+]), are not known.
A clarifying contribute may derive from the use of simple
NMJ inhibitory agents such as the lysoPLs, which are the
product of the phospholipase A2 enzymatic activity of these
neurotoxins [16]. In low [Mg2+], a lysoPC + OA mixture
caused a decrease of neurotransmission that proceeded until
complete blockade; the onset of paralysis was preceded by a
signiﬁcant lag phase (Fig. 1D), similar to that observed with
SPANs under the same experimental conditions (Fig. 1C). Un-
like lysoPC, all the other lysoPL mixtures, at the concentration
tested here, failed to paralyze the NMJ in low [Mg2+] (not
shown). Total block of neurotransmission was achieved faster
for both lysoPC + OA and SPANs in high [Mg2+], though this
lipid mixture failed to reproduce the triphasic proﬁle typical of
SPANs (Fig. 1B). Nevertheless one cannot exclude that the
initial inhibitory phase was present but superimposed to the
run-down phase (Fig. 1B).
We tested a group of lysoPL that include zwitterionic lipids
like lysophosphatidylethanolamine (lysoPE), and negatively
charged lysoPLs, like lysophosphatidylserine (lysoPS), lyso-
phosphatidic acid (lysoPA), and lysophosphatidylglycerol
(lysoPG). In high [Mg2+], all these lipids were able to com-
pletely paralyze the NMJ, although with diﬀerent potency.
Fig. 2. Paralysis of the neuromuscular preparation caused by diﬀerent
lysoPLs in high [Mg2+] bathing medium. Typical paralysis proﬁles
obtained after addition of the speciﬁed lysophospholipid; abbrevia-
tions used are as given in the text. The negatively charged lysoPLs
cause a rapid depression of the muscle twitch, comparable to phase (1)
described in Fig. 1 for the snake neurotoxins. LysoPS and lysoPG also
induced a facilitation phase similar to the phase (2) of snake
neurotoxins shown in Fig. 1; this latter facilitation eﬀect is absent in
the case of lysoPA. Zwitterionic lysoPLs (lysoPC and LysoPE) cause a
more rapid paralysis of NMJ with a run-down curve. Lipids are added
at time 0.
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given in Table 1 for lysoPLs and for their equimolar mixture
with OA. The lysoPL alone is suﬃcient to inhibit the synapse
in high [Mg2+], with a paralysis time shorter than, or equal to
that induced by their mixture with OA, suggesting that lysoli-
pids are the major eﬀectors of the NMJ blockade. Only lysoPE
has a potency comparable to LysoPC, whereas all the other
lysoPL tested are much less eﬀective. At variance, in low
[Mg2+] lysoPC alone gave a partial inhibitory eﬀect, and full
inhibition was only achieved when it was mixed with OA
[16]. Clearly, [Mg2+] is a major determinant of both the inhib-
itory potency and the shape of the curve of lysoPL induced
paralysis. All these lysoPLs do not paralyse the muscle directly
as no change in muscle twitch was found with direct muscle
stimulation (not shown).
3.2. Diﬀerent lysophospholipids induce diﬀerent paralysis proﬁles
of the neuromuscular junction
Membrane phospholipids diﬀer not only for their head
groups but also with respect to their FAs. We used the oleoyl
or myristoyl derivatives, depending on commercial availability.
The myristoyl derivatives were found to be more potent than
their oleoyl counterparts, possibly because of their more pro-
nounced inverted cone shape, due to the shorter hydrocarbon
chain, and to their more eﬃcient partition into the plasma
membrane.
Fig. 2 shows the NMJ paralysis proﬁles of diﬀerent lysoPLs
in high [Mg2+]. The shape of curves obtained is very similar for
lysoPL alone and for lysoPL/OA mixtures (not shown).
LysoPC and lysoPE paralyze the NMJ with a simple run-down
curve. A very interesting ﬁnding is that lysoPS and lysoPG
induce a triphasic curve of paralysis, reminiscent of that elic-
ited by SPANs; lysoPA causes a biphasic curve with a rapid
initial inhibition which then progresses at a lower rate. This
mimicking of the ﬁrst phase of the SPAN-induced neuromus-
cular paralysis by some lysoPL is puzzling and interesting at
the same time because it challenges previous conclusions that
the initial SPAN-induced inhibitory phase was not dependent
on PLA2 activity [5,7,8].Table 1
Comparison of the neuromuscular paralysis time induced by diﬀerent
lysoPLs and lysoPls mixtures with OA
High Mg (5–7 mM)
lysoPL lysoPL + OA
T50% RPa T50% RPa
LPC myristoyl 10 0 ± 3 n = 3 100 140 ± 4 n = 7 100
LPC oleoyl 19 0 ± 11 n = 5 53(100) 350 ± 8 n = 5 45(100)
LPE myristoyl 18 0 ± 13 n = 3 55 370 ± 9 n = 3 38
LPA oleoyl 79 0 ± 48 n = 4 8(24) 1880 ± 13 n = 3 7(19)
LPS oleoyl 172 0 ± 49 n = 4 6(11) 1770 ± 52 n = 4 8(20)
LPG myristoyl 230 0 ± 99 n = 4 4 2240 ± 50 n = 4 6
The inhibitory activity of lysophospholipids is expressed as the time
required to reduce the muscular twitch to 50% of its initial value
(T50%). Comparison between the relative potency (RP) of the diﬀerent
lysoPL was made by taking the T50% of myristoyl-lysoPC as 100%.
The same comparison made for the oleoyl derivatives are given in
parenthesis.
aRP = relative potency (T50% LPC/T50% other lipid ·100).3.3. Reversibility of paralysis of the neuromuscular junction
The partition of lysoPL and FA into the presynaptic mem-
brane from the medium is responsible for the blockade of
the nerve terminals. Conversely, one would expect that their
removal from the membrane would restore synaptic function,
if a permanent damage is not established within the present
experimental time. Removal of FA and their derivatives can
be achieved by addition of albumin, a serum protein which
contains several FA binding sites [21,22]. Fig. 3 shows a typical
twitch proﬁle of the lysoPC+OA treated NMJ in high [Mg2+];
the simple washing with a lipid-free and albumin containing
medium completely restores the nerve-stimulated muscle
twitch. Recovery of NMJ function was completed within few
minutes, suggesting that the lysoPL and FA equilibration
between the membrane and the medium and their binding to
albumin are very rapid. Similar recoveries were obtained with
the other lysoPL tested here (not shown). Rapid albumin bind-
ing of FA and FA derivatives with consequent eﬀect of the
membrane fusion of liposomes was very recently reported
[23]. If the NMJ paralysis induced by SPANs is indeed medi-
ated by lysoPL and FA, for the same physico-chemical rea-
sons, albumin washing should be eﬀective also in the case of
the SPAN-induced inhibition. Fig. 3 shows that this is indeed
the case. However, recovery is only partial and then paralysis
progresses again. The same pattern was recorded with all tox-
ins tested in high [Mg2+]. This temporary relief of inhibition is
expected on the basis of the known fact that SPAN binding be-
comes rapidly irreversible, as SPANs cannot be washed away
and become insensitive to the action of speciﬁc anti-toxin anti-
bodies [24,25]. Thus, the toxin can continue to hydrolyse phos-
pholipids on the presynaptic membrane, with the production
of the lysoPL and FA which then inhibit the synapse.
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Fig. 3. Albumin washing reverses the neuromuscular paralysis induced
by SPANs or by lysoPLs. A muscle was bathed in physiological buﬀer
and, after stabilization of its twitching strength, Mg2+ was added as
described in materials and methods . When twitch was stabilized to its
typical high [Mg2+] value (100%), the lipid mixture was added. At
complete paralysis the lysoPL-containing medium was replaced with a
medium containing 0.2% albumin (arrow) in physiological buﬀer. The
albumin washing restored the twitch amplitude to the initial values
(left panel). A similar behaviour was obtained after intoxication with
all SPANs tested, but in this case the recovery was partial and
temporary (right panel).
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Previous studies have provided evidence that the facilitation
phase of SPAN action on the NMJ corresponds to stimulation
of exocytosis, whereas the third phase is characterized by inhi-
bition of endocytosis and SV recycling. The nature of the ﬁrst
transient phase of inhibition remains unexplained. Here, we
show that this initial depression of the NMJ function is linked
to the presence of high [Mg2+], and therefore is not likely to be
present in vivo, during envenomation. This ion appears to act
on the presynaptic membrane rather than on the SPAN itself,
as there are lysoPLs (lysoPS, lysoPG) which mimic the toxin
eﬀect, with a triphasic paralysis proﬁle, and high [Mg2+] does
not aﬀect the phospholipase A2 activity of SPAN (our unpub-
lished observations). We propose here that Mg2+ at high con-
centrations interacts with the ‘‘active zones’’ of the presynaptic
membrane, which are the preferred sites of SV fusion with the
plasma membrane, making them more sensitive to membrane
fusion with SVs. This suggestion is based on the following
observations: (a) lysoPL alone are able to inhibit the NMJ in
high [Mg2+], while lysoPC association with FA is required
for inhibition in low [Mg2+] [16]; (b) no lag phase is present
in the action of SPAN and of lysoPL in high [Mg2+]; (c) gen-
erally, paralysis develops more rapidly in high [Mg2+]. All
these experimental features speak in favour of a facilitated
SV fusion with the presynaptic membrane. The implication
of ‘‘active zones’’ in the inhibitory eﬀect of SPANs and lysoPL
also oﬀers an explanation for the diﬀerent lipid behaviour
found here with respect to the ﬁrst inhibitory phase. In fact,
LysoPG, LysoPS and lysoPA, possibly owing to their net neg-
ative charge, may insert into the ‘‘active zones’’ and change
their structure in such a way as to make them less prone to fuse
with SVs. On the contrary, the initial lysoPC or lysoPE parti-
tion into these zones does not aﬀect their propensity to fuse.
When more lysoPC or lysoPE are incorporated into the ‘‘active
zones’’ their eﬀects on membrane curvature develops and then
aﬀect exocytosis and endocytosis. The initial inhibitory eﬀect
of lysoPG, lysoPS and lysoPA is overcome as more of them
are incorporated, thus becoming suﬃcient to promote the pore
formation which leads to acetylcholine release. The situation is
diﬀerent with SPANs as they release the products of phospho-lipids hydrolysis at their membrane binding sites. The data
would be reconciled if one considers our recent proposal that
SPANs bind within the ‘‘active zones’’ of the presynaptic mem-
brane [4].
Another aim of the present work was to test the possibility
that lysoPL others than lysoPC could be more powerful in
paralysing the NMJ, but none of them was found to be more
eﬀective than lysoPC. This indicates that the more common ly-
soPC is probably the best lysoPL to be used in studies of the
mechanism of membrane fusion. This ﬁnding may also have
an evolutionary signiﬁcance as phosphatydylcholine is by far
the major class of phospholipids present on the outer leaﬂet
of the presynaptic membrane which is the ﬁrst one to become
accessible to the snake neurotoxins.
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